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Abstract Accumulating evidence suggests that tyrosine phos-
phorylation plays an important role in the development of the 
central nervous system and in the differentiation of neuronal 
cells. To identify protein tyrosine phosphatases (PTPs) that 
might regulate signaling events leading to neuronal cell 
differentiation, we cloned PTP genes from the murine P19 
embryonic carcinoma cell line and examined the change of their 
expression during differentiation. P19 cells are known to be 
pluripotent and the aggregate formation and subsequent replat-
ing in the presence of retinoic acid (RA) induce growth arrest and 
neuronal differentiation. The results demonstrated that among 
several PTP genes expressed in P19 cells, a cytosolic Src 
homology region 2 domain-containing PTP, SHP-1, is expressed 
highly in undifferentiated P19 cells, but is reduced to an 
undetectable level at day 3 after replating in the presence of 
RA. Further, SHP-1 was tyrosine-phosphorylated and activated 
at day 1 after replating. When ectopic SHP-1 was constitutively 
expressed, P19 cells continued to proliferate and failed to 
differentiate upon stimulation with RA. Collectively, these results 
suggest that the regulated expression and activity of SHP-1 may 
be involved in the neuronal differentiation of P19 cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Protein tyrosine phosphorylation is one of the main mech-
anisms controlling cell proliferation and differentiation [1-3]. 
The level of phosphorylation on tyrosine residues of intracel-
lular proteins is tightly regulated by the balance between the 
activities of protein tyrosine kinases (PTKs) and protein ty-
rosine phosphatases (PTPs). Since the first cytosolic PTP 
(PTP1B) was cloned from human placenta [4], a number of 
receptor-type (RPTP) and cytosolic PTP genes have been 
cloned in several species. However, their roles in specific cel-
lular processes are largely unclarified. 
In the brain, cytosolic PTKs such as Src, Fyn and Yes are 
abundantly expressed in a developmental stage-specific man-
ner [5-7], and are localized at high levels in growth cones [8], 
especially in growth cone particles [9]. Several growth factors 
in the nervous system such as fibroblast growth factor, epi-
dermal growth factor (EGF) and nerve growth factor (NGF) 
can promote cell proliferation and neurite outgrowth by bind-
ing to and activating their receptors with PTK activities. Re-
cent studies suggest that both cytosolic [10,11] and receptor-
*Corresponding author. Fax: (81) (423) 21-8678. 
E-mail: yakura@tmin.ac.jp 
type PTKs [12] function downstream of cell adhesion mole-
cules, controlling neurite outgrowth. All these examples indi-
cate important roles of tyrosine phosphorylation in neuronal 
cell differentiation and neural development. 
There have been many reports suggesting that PTPs are 
major regulators in the nervous system. For example, several 
RPTPs, such as PTPS [13,14], PTPo [15-19], LAR [15,20] and 
RPTPß [21], are highly expressed in the neuronal tissues of the 
vertebrates. The carbonic anhydrase domain of RPTPß/PTPC 
is a ligand for the axonal recognition molecule contactin [22]. 
Further, four out of five RPTPs identified in Drosophila are 
expressed predominantly on axons in the developing nervous 
system [23-26]. Recent studies provide evidence that three 
such RPTPs, DLAR [27], DPTP69D and DPTP99A [28], 
are required for the guidance of specific motor axons during 
Drosophila embryonic development. 
In this study, we investigated the possible involvement of 
PTPs in in vitro neuronal cell differentiation of murine P19 
embryonic carcinoma (EC) cells. PI 9 cells are widely used as a 
model system for murine pre-implantation development [29-
31]. For the induction of neuronal differentiation, P19 cells 
are allowed to form aggregation for 3 days and replated for 3 -
4 days in the presence of retinoic acid (RA). P19 cells can also 
differentiate into mesodermal and endodermal cells with di-
methylsulfoxide (DMSO) stimulation and without any in-
ducers, respectively. Here we demonstrate that undifferenti-
ated PI9 cells express Src homology region 2 (SH2) domain-
containing phosphatase 1, SHP-1 [32-35], and the expression 
of SHP-1 is reduced to a background level at the terminal 
differentiation stage into neuroectodermal cells. Constitutive 
overexpression of ectopic SHP-1 in P19 appeared to suppress 
neuronal differentiation and induce continuous proliferation. 
Thus SHP-1 may play a critical role in the neuronal differ-
entiation and growth control of P19 cells. 
2. Materials and methods 
2.1. Cells 
PI9 EC cell line was purchased from American Type Culture Col-
lection (Rockville, MD). Cells were maintained in a-modified mini-
mum essential medium supplemented with 20 mM L-glutamine and 
10% fetal bovine serum. Aggregation of the P19 cells was done by 
culturing cells on poly(2-hydroxyethyl methacrylate) (poly-HEMA)-
coated Petri dishes for 3 days. Subsequently, the aggregates were 
replated on tissue culture dishes for 3 days. Endoderm-like cells 
were induced in this culture. For the induction of neuroectoderm-
and mesoderm-like cells, aggregate formation and replating into 
monolayer cultures were performed in the presence of 0.1 LIM RA 
and 1% DMSO, respectively. 
2.2. Antibodies and reagents 
Polyclonal rabbit anti-human SHP-1 antibody (Ab), which cross-
reacts with the mouse product, was purchased from Santa Cruz Bio-
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technology (Santa Cruz, CA). Anti-phosphotyrosine (PY) monoclonal 
antibody (mAb) 4G10 was purchased from Upstate Biotechnology 
(Lake Placid, NY). Alkaline phosphatase (AP)-conjugated goat anti-
mouse IgG and AP-conjugated mouse anti-rabbit IgG were obtained 
from Bio-Rad Laboratories (Richmond, CA) and Jackson ImmunoR-
esearch Laboratories (West Grove, PA), respectively. Poly-HEMA 
was purchased from Sigma (St. Louis, MO). 
2.3. RT-PCR and cDNA cloning 
RT-PCR was performed as described previously [36]. The first 
strand cDNA was synthesized using oligo (dT) primer. The synthe-
sized cDNA was directly used as a template for PCR amplification. 
To obtain genes for PTPs, two sets of PCR were performed using the 
following degenerative primers which correspond to highly conserved 
catalytic domain amino acid sequences DFWRM(I/V)W (upstream), 
KC(D/A)(K/E/Q)YWP (internal) and HCSAGVG (downstream): 5'-
GA(C/T)TC(T/C)TGG(A/C)G(A/G)ATGA(C/T)CTGG-3' (sense pri-
mer for the first PCR), 5'-AA(A/G)TG(C/T)(C/G)(A/C)(C/T)CA(A/ 
G)TA(C/T)TGGCC-3' (sense primer for the second PCR), and 5'-
CC(A/T)TC(G/T)CC(A/C)GC(A/G)CT(A/G)CA(A/G)TG-3' (anti-
sense primer for the first and second PCRs). The PCR product of 
about 260 bp after the second PCR was blunt-ended, cloned in 
pUC18 using SureClone Ligation Kit (Pharmacia Biotech, Uppsala, 
Sweden) and sequenced by the dideoxy chain termination method. 
The SHP-1 and SHP-2 gene expression was examined by RT-PCR 
using oligo (dT)-primed cDNA and the following primers were used 
for SHP-1: 5'-TGGTTTCACCGGGACCTCAGC-3' (sense primer) 
and 5'-AGTAAGGGTGCCGCAGGTAGA-3' (antisense primer), 
which amplify cDNA fragments encoding amino acids 4-213, and 
for SHP-2: 5'-TGGTTTCACCCAAATATCACT-3' (sense primer) 
and 5'-GGGCTGCTTGAGTTGTAGTAC-3' (antisense primer), 
which amplify cDNA fragments encoding amino acids 6-215. For 
the internal control, synthesized cDNA was amplified with glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH)-specific primers (Clon-
tech, Palo Alto, CA). 
2.4. Immunoprecipitation and Western blot analysis 
Immunoprecipitation and Western blot analysis were performed as 
described previously [37]. Cells were harvested, washed twice with ice-
cold PBS containing 1 mM Na3V04 and 2 mM EDTA, and lysed in 
TNE lysis buffer (1% NP-40, 20 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1 mM Na3V04, 2 mM EDTA, 1 mM PMSF, and 0.15 U/ml 
aprotinin). After centrifugation, protein concentration was adjusted 
and each sample was immunoprecipitated with protein G-Sepharose 
coupled with anti-SHP-1 Ab. Total cell lysates or immunoprecipitates 
were subjected to 7.5% SDS-PAGE and blotted onto a nitrocellulose 
membrane. The membranes were incubated overnight with anti-PY 
mAb or anti-SHP-1 Ab, followed by incubating AP-conjugated goat 
anti-mouse IgG or mouse anti-rabbit IgG, respectively. The blots were 
visualized by developing with nitroblue tetrazolium and 5-bromo-4-
chloro-3-indolyl phosphate. 
2.5. FTP assay 
PTP activity was assayed in 200 ill citrate buffer (100 mM, pH 5.0) 
containing immunoprecipitated SHP-1 and /7-nitrophenyl phosphate 
(pNPP) as a substrate and at 37°C for 20 min. The reaction was 
stopped by the addition of 200 ul 1 N NaOH, and the absorbance 
was measured at 405 nm. 
2.6. Plasmid and transfection 
To generate an expression construct for SHP-1, a full-length SHP-1 
cDNA was inserted in pcDNA3 vector (Invitrogen, San Diego, CA). 
Stable transfectants were obtained using the calcium phosphate pre-
cipitation method, followed by selection with 300 u.g/ml geneticin 
Table 1 
PTP genes expressed in neuronally differentiated P19 cells 
PTPa P19-PTP P 
Aggregate day 1 16 4 3 
Replate day 2 9 1 0 
Fig. 1. Altered tyrosine phosphorylation of cellular proteins during 
in vitro differentiation of P19 cells. Western blot analysis using anti-
PY mAb of cell lysates from PI9 cells during neuronal differentia-
tion. For the induction of neuroectoderm-like cells, P19 cells were 
allowed to form aggregate by culturing cells on poly-HEMA-coated 
Petri dishes for 3 days in the presence of 0.1 uM RA, and then the 
aggregates were replated on tissue culture dishes for 3 days. 20 |xg 
of cell lysate was separated on a 10% SDS-PAGE gel. After transfer 
to a nitrocellulose membrane, Western blot was performed with 
anti-PY mAb. 
(Gibco BRL, Gaithersburg, MD) for 14 days. Colonies were picked 
up and clones were established by limiting dilution. 
3. Results 
3.1. Tyrosine phosphorylation of cellular proteins in neuronally 
differentiated P19 cells 
P I 9 cells are known to differentiate in vitro into mesoder-
mal and neuroectodermal cells upon D M S O and R A stimu-
lation, respectively, or endodermal cells without any inducers. 
As a first step, we investigated tyrosine phosphorylation of 
cellular proteins during neuronal differentiation of P19 cells. 
Fo r the induction of neuroectoderm-like cells, P19 cells were 
allowed to form aggregate by culturing cells on po ly-HEMA-
coated Petri dishes for 3 days in the presence of 0.1 u\M R A , 
and then the aggregates were replated on tissue culture dishes 
for 3 days. Western blot analysis of total cellular proteins 
using anti-PY m A b demonstrated that in the presence of 
R A tyrosine phosphorylation of 110 k D a and 60 k D a proteins 
was reduced at days 1-3 and days 1-2 of aggregate formation, 
respectively (Fig. 1). After replating of aggregates, tyrosine 
phosphorylation was markedly induced at day 1 in many spe-
cies of proteins, e.g. 60 kDa, 75 kDa, 80 kDa, 100 k D a and 
150 kDa, but returned to the baseline level at day 2 (Fig. 1). 
PTPÇ PTP-MEG CD45 SHP-1 
3 0 3 5 
0 2 2 3 
RNA isolated at 1 day after aggregation or at 2 days after replating in the presence of RA was used as a template for cDNA synthesis. The number 
of isolated clones corresponding to each PTP gene is indicated. 
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Fig. 2. Expression of SHP-1 and SHP-2 in the neuronally differenti-
ating P19 cells. A: Gene expression of SHP-1 and SHP-2 was exam-
ined by RT-PCR. Oligo (dT)-primed cDNA was subjected to PCR 
reaction with each set of primers as described in Section 2. B: 20 
ug of total cell lysate was size-fractionated on a 10% SDS-PAGE 
gel. After transfer to a nitrocellulose membrane, Western blot was 
performed with anti-SHP-1 Ab. 
These changes were not detected in the mesodermal or endo-
dermal differentiation process (data not shown). 
3.2. PCR cloning of PTP genes expressed in differentiated 
P19 cells 
To investigate PTPs involved in the regulation of neuronal 
differentiation of PI9 cells, we cloned PTPs expressed in P19 
cells by RT-PCR with degenerative primers specific for the 
conserved regions in the PTP domains. RNA isolated at 
1 day after aggregation or at 2 days after replating was used 
as a template for cDNA synthesis. PCR products were blunt-
ended and cloned in pUC18. Sequence analysis and subse-
quent GenBank database search revealed that all clones dis-
play significant homology to catalytic domains of known PTP 
genes (Table 1). No novel PTP sequences were found. The 
most frequently isolated clones (16 clones from aggregates 
and nine clones from replate cultures) corresponded to either 
the first or the second catalytic domain of PTPa, which was 
previously shown to be expressed in P19 cells [38]. The second 
group consisted of five clones (four clones from aggregates 
and one clone from replate cultures) with sequences identical 
to P19-PTP, which was originally cloned from P19 cells [39]. 
In addition to PTPa and P19-PTP, PTPe, PTPÇ, PTP-MEG, 
CD45 and SHP-1 were identified (Table 1). Among these 
PTPs, we focused on SHP-1 that was reported to be expressed 
in neuronal tissues or cell lines [40,41]. 
3.3. SHP-1 expression is reduced after replating during 
neuronal differentiation 
SHP-1 is a cytosolic PTP that contains two tandem SH2 
domains at the N-terminus and is preferentially expressed in 
hematopoietic cells [32-35]. In mammals, another SH2 do-
main-containing PTP, SHP-2, is known to be present in a 
wide range of tissues [42-45]. To gain insight into possible 
involvement of SHP-1 in neuronal cell differentiation, we de-
termined the changes of SHP-1 gene expression (Fig. 2A). RT-
PCR analysis revealed that undifferentiated P19 cells express 
SHP-1 mRNA, which was maintained during aggregate for-
mation in the presence of RA. However, upon replating of 
aggregates, the expression of SHP-1 was reduced to an almost 
undetectable level. The pattern of SHP-1 protein expression 
was correlated well with that of SHP-1 gene expression (Fig. 
2B). In contrast, such alteration was not observed during 
endodermal or mesodermal differentiation which was induced 
as mentioned in Section 2 (Fig. 3). SHP-2 expression was not 
Fig. 3. SHP-1 and SHP-2 expression in P19 cells during endodermal or mesodermal differentiation, which are induced as described in Section 
2. Total RNA was prepared from P19 cells during endodermal or mesodermal differentiation and cDNA was synthesized with oligo (dT) pri-
mer. PCR reaction was performed as described in the legend to Fig. 2. 20 ug of cell lysate was used for anti-SHP-1 Western blotting. 
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changed significantly during differentiation into derivatives of 
three germ layers (Fig. 2AFig. 3). Thus SHP-1 may play a 
unique regulatory role selectively in neuronal differentiation 
of PI 9 cells. 
3.4. SHP-1 is transiently tyrosine-phosphorylated and activated 
during neuronal differentiation 
Since tyrosine phosphorylation of SHP-1 has been reported 
to induce the enzymatic activity [41,46], we examined whether 
the state of tyrosine phosphorylation in SHP-1 is altered dur-
ing cultures of P19 cells in the presence of RA. Total cell 
lysates from RA-treated cells were immunoprecipitated with 
anti-SHP-1 Ab and then subjected to Western blot analysis 
with anti-PY mAb. This experiment revealed that tyrosine 
phosphorylation of SHP-1 is transiently enhanced at day 1 
after replating (Fig. 4). No other phosphotyrosine-containing 
proteins were present in the SHP-1 immunoprecipitates, 
although GST-SHP-1-SH2 fusion proteins could precipitate 
several phosphotyrosine-containing proteins in vitro (data 
not shown). We further tested the PTP activity of SHP-1 
immunoprecipitated from undifferentiated or differentiated 
P19 lysates. The results shown in Fig. 5 clearly demonstrated 
that the PTP activity of SHP-1 is transiently upregulated on 
day 1 after replating, when tyrosine phosphorylation of SHP-
1 is enhanced. This upregulation of PTP activity was proved 
to be significant (P<0.01) by paired i-test. 
t« 
(1X0.01) 
I 
aggregate replate 
Fig. 5. PTP activity of SHP-1 is upregulated on day 1 after replat-
ing. SHP-1 immunoprecipitates were suspended in 200 ul citrate 
buffer (100 mM, pH 5.0) containing />NPP and incubated at 37°C 
for 20 min. The reaction was stopped by adding 1 N NaOH. The 
absorbance was measured at 405 nm. Three independent experi-
ments were performed and mean absorbance ± S.E.M. was shown. 
3.5. Effect of ectopic SHP-1 expression on neuronal 
differentiation of P19 cells 
Finally, to investigate whether reduced SHP-1 expression is 
required for neuronal differentiation, exogenous SHP-1 was 
stably expressed in P19 cells. CMV promoter-driven expres-
sion vector for SHP-1 was constructed by insertion of a full-
length SHP-1 cDNA into the mammalian expression vector 
pcDNA3. After geneticin selection for 2 weeks, several clones 
were established by limiting dilution. SHP-1 gene and protein 
expression in two representative clones (10 and 16) is shown 
in Fig. 6A,B, respectively. Basal PTP activity of SHP-1 im-
munoprecipitates from PI9, mock-transfected PI9 cells, clone 
10 and 16 was 1.0, 1.0, 1.16 and 1.20, respectively (data not 
shown). SHP-1 remained to be highly expressed in the two 
clones until day 3 after replating (data not shown). To deter-
mine the effect of constitutive expression of SHP-1 on the fate 
of differentiation of P19 cells, we examined the ability of the 
SHP-1-transfected clones to extend neurite outgrowth in re-
sponse to RA. In contrast to PI9 cells transfected with vector 
alone which showed growth arrest and significant neurite ex-
tensions, SHP-1-transfected clones continued to proliferate 
even after replating and had less neurite extensions even at 
day 3 after replating (Fig. 6C). 
4. Discussion 
Fig. 4. SHP-1 is transiently tyrosine-phosphorylated after replating 
RA-treated aggregates. P19 cells were treated with RA to induce 
neuronal differentiation. SHP-1 was immunoprecipitated from 2 mg 
of total cellular proteins, subjected to SDS-PAGE and immunoblot-
ted with anti-PY mAb. The lower panel shows the relative amount 
of SHP-1 in each immunoprecipitate. 
In this report, we investigated the role of PTPs in neuronal 
cell differentiation using P19 cells as a model of in vitro differ-
entiation. PI 9 cells are murine pluripotent EC cells that are 
known to differentiate into derivatives of all three germ layers 
by different stimulations [29-31]. In endodermal or mesoder-
mal differentiation of PI9 cells, tyrosine phosphorylation of 
cellular proteins was almost unchanged (data not shown). In 
contrast, slightly reduced tyrosine phosphorylation of a few 
proteins (110 kDa and 60 kDa) was obtained during RA-
induced aggregate formation, and enhanced tyrosine phos-
phorylation was observed in several protein species (60 kDa, 
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Fig. 6. Constitutive expression of ectopic SHP-1 inhibits RA-induced neurite extensions and growth arrest in P19 cells. A: Gene expression of 
SHP-1 was examined by RT-PCR analysis in 2 SHP-1 transfectants, a clone transfected with empty vector, and wild-type P19 cells. B: Relative 
amount of SHP-1 protein expression in each clone was examined by Western blot analysis. 20 ug of total cell lysate was subjected to SDS-
PAGE and immunoblotted with anti-SHP-1 Ab. C: Each clone was allowed to form aggregates, replated in the presence of RA and photo-
graphed at 3 days after replating. Note that SHP-1 transfectants continue to proliferate and have fewer neurite extensions. 
75 kDa, 80 kDa, 100 kDa and 150 kDa) at day 1 after replat-
ing (Fig. 1). When a specific PTP inhibitor Na3VC>4 was 
added to cultures, neurite outgrowth and MAP-2-positive cells 
were strongly reduced, suggesting a possible involvement of 
PTPs in this process (data not shown). 
Previously, P19 cells were shown to express two PTP genes, 
PTPa [38] and P19-PTP [39]. P19-PTP mRNA was reported 
to be detected upon aggregation of PI9 cells either in the 
absence of chemical inducers or in the presence of DMSO 
or RA and to be reduced to an undetectable level upon re-
plating of aggregates [39]. P19-PTP showed the highest ex-
pression during the period of corticogenesis [40], implying a 
role in the regulation of proliferation and determination of 
neuronal fate, den Hertog et al. demonstrated that endoge-
nous PTPa expression is enhanced during neuronal differen-
tiation of PI9 cells and that overexpression of PTPa alters the 
differentiation fate of PI9 cells in favor of neuronal differ-
entiation [38]. In addition, c-Src was shown to be activated 
in PTPa-transfected cells, suggesting PTPa-mediated activa-
tion of c-Src. Studies on knockout mice for c-Src and c-Fyn 
demonstrated that LI-dependent neurite outgrowth is im-
paired in vitro in neurons from Src-deficient mice [47] and 
that NCAM-dependent neurite outgrowth is inhibited in neu-
rons from Fyn~ mice [48]. Taken together, it is possible that 
individual PTK functions downstream of specific CAMs, 
whose activity is in turn regulated by a specific PTP. In this 
study, enhanced tyrosine phosphorylation was observed in 60 
kDa proteins at 1 day after replating (Fig. 1). It remains to be 
determined whether this molecule is c-Src or other Src-family 
PTKs. 
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The present study further identified PTPE, PTPÇ, PTP-
MEG, CD45 and SHP-1 in P19 cells (Table 1). We focused 
on cytosolic PTPs containing two SH2 domains at the N-
terminus, SHP-1 and SHP-2 for further analysis. Recent 
data have demonstrated that the gene encoding SHP-1 is mu-
tated in motheaten and viable motheaten mice resulting in 
autoimmune disease and immunodeficiency [49,50] and that 
SHP-1 negatively regulates B cell antigen receptor-initiated 
signaling [51,52]. In contrast to ubiquitous SHP-2, SHP-1 is 
preferentially expressed in hematopoietic cells [32-35,53], but 
is also found in cells of epithelial origin [53] and in the brain 
[40]. We found that SHP-1 but not SHP-2 expression is de-
creased after replating RA-treated P19 aggregates (Fig. 2) and 
that the constitutive expression of ectopic SHP-1 inhibits 
strongly neuronal cell differentiation (Fig. 6). Furthermore, 
SHP-1 was tyrosine-phosphorylated and activated transiently 
during neuronal differentiation (at 1 day after replating) (Figs. 
4 and 5). Since protein expression of SHP-1 has already been 
decreased at 1 day after replating (Fig. 4), the degree of ty-
rosine phosphorylation and activation per SHP-1 molecule 
should be more prominent. These results suggest that timely 
activation of SHP-1 and downregulation of SHP-1 may be 
critical to the final differentiation into neuronal cells and the 
continuous expression of SHP-1 has negative effect on this 
process. 
The mechanisms whereby SHP-1 regulates neuronal differ-
entiation in P19 cells are currently open. SHP-1 may act on a 
molecule that is specifically expressed at or selectively required 
for this particular step of differentiation. To define the role of 
SHP-1, it will be important to identify the physiological sub-
strate in neuronal cells. There was no difference in tyrosine 
phosphorylated proteins in anti-SHP-1 immunoprecipitates 
between SHP-1-activated and -non-activated phases (Fig. 4). 
If a putative substrate is present at all stages of differentiation, 
this result suggests that a putative substrate may not be in 
anti-SHP-1 immunoprecipitates. Together with characteriza-
tion of SHP-1-binding proteins, we are in the process of per-
forming 'substrate trapping' experiments using a catalytically 
inactive form of SHP-1. 
Sahin et al. demonstrated that the expression level of SHP-1 
transcript remains constant during cortical development [40]. 
However, they failed to detect in situ hybridization signals in 
the developing cortex of the E17 embryo, leading them to 
conclude that SHP-1 expression in the brain might be due 
to the contamination of the blood cells. In contrast, Vambu-
tus et al. [41] showed that SHP-1 may play a role in neuronal 
differentiation in NGF-induced differentiation of PC12 cells. 
In PC 12 cells, SHP-1 was shown to be tyrosine-phosphory-
lated and activated after stimulation with NGF but not EGF 
and to bind NGF receptor TrkA in vitro in an NGF-depend-
ent manner. Our results provide further evidence that SHP-1 
is a crucial regulator in neuronal differentiation. It is of inter-
est where in the brain SHP-1 is expressed and whether SHP-1 -
deficient motheaten mice display any neurological disorders. 
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